For instance, if the process of Bet1L protein downregulation has already been initiated in the pre-symptomatic ALS rats, additional gene silencing could sufficiently make Bet1L protein expression below the biologically required level to maintain NMJ innervation in ALS rats. This evidence concerns the gene BET1L and amyotrophic lateral sclerosis.